120
Participants
Start Date
September 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
January 31, 2027
Participants will prepare their cannabis product ad libitum and inhale the prepared product as usual for a maximum of 15 minutes.
Participants will prepare and inhale their cannabis product ad libitum for a maximum of 15 minutes. Prior to inhaling cannabis (the baseline), and for three hours thereafter, biological samples (e.g., blood) will be collected. Participants will be asked to complete a series of questionnaires addressing their (subjective) neurocognitive function and well-being, as well as their self-rated driving ability and subjective cannabis effects.
University Psychiatric Clinics Basel, University of Basel, Basel, Switzerland
UNKNOWN
Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland
UNKNOWN
Biopharmacy, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
UNKNOWN
Institute of Forensic Medicine, University of Basel, Basel, Switzerland
UNKNOWN
University of Basel
OTHER